Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0062 | 0 | 0.5 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.3211 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3211 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0062 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0062 | 0 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0062 | 0 | 0.5 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.1909 | 0.5866 | 0.5866 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0062 | 0 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0062 | 0 | 0.5 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0062 | 0 | 0.5 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0062 | 0 | 0.5 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0062 | 0 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0062 | 0 | 0.5 |
Onchocerca volvulus | 0.3211 | 1 | 0.5 | |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.1302 | 0.3939 | 0.3939 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0062 | 0 | 0.5 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.3211 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0062 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0062 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0062 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AP (functional) | = 42.9 uM | Average potency against P388 cells | ChEMBL. | 10212121 |
AP (functional) | = 42.9 uM | Average potency against P388 cells | ChEMBL. | 10212121 |
AP (functional) | = 127 uM | Average potency against L1210 cells | ChEMBL. | 10212121 |
AP (functional) | = 127 uM | Average potency against L1210 cells | ChEMBL. | 10212121 |
AP (functional) | = 155 uM | Average potency against CEM cells | ChEMBL. | 10212121 |
AP (functional) | = 155 uM | Average potency against CEM cells | ChEMBL. | 10212121 |
AP (functional) | = 267 uM | Average potency against Molt4/C8cells | ChEMBL. | 10212121 |
AP (functional) | = 267 uM | Average potency against Molt4/C8cells | ChEMBL. | 10212121 |
IC50 (functional) | = 38.6 uM | Inhibitory activity was tested against P388 cells | ChEMBL. | 10212121 |
IC50 (functional) | = 38.6 uM | Inhibitory activity was tested against P388 cells | ChEMBL. | 10212121 |
IC50 (functional) | = 59.1 uM | Inhibitory activity was tested against L1210 cells | ChEMBL. | 10212121 |
IC50 (functional) | = 59.1 uM | Inhibitory activity was tested against L1210 cells | ChEMBL. | 10212121 |
IC50 (functional) | = 67.1 uM | Inhibitory activity was tested against CEM cells | ChEMBL. | 10212121 |
IC50 (functional) | = 67.1 uM | Inhibitory activity was tested against CEM cells | ChEMBL. | 10212121 |
IC50 (functional) | > 500 uM | Inhibitory activity was tested against Molt4/C8 cells | ChEMBL. | 10212121 |
IC50 (functional) | > 500 uM | Inhibitory activity was tested against Molt4/C8 cells | ChEMBL. | 10212121 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.